Reference
Romero A, et al. Hemophagocytic syndrome following alemtuzumab treatment for multiple sclerosis: A case report. Multiple Sclerosis and Related Disorders 40: 101973, May 2020. Available from: URL: http://doi.org/10.1016/j.msard.2020.101973
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1793, 25 (2020). https://doi.org/10.1007/s40278-020-75367-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-75367-y